CGON logo

CG Oncology, Inc. (CGON) EBIT

Annual EBIT:

-$114.67M-$59.22M(-106.80%)
December 31, 2024

Summary

  • As of today, CGON annual earnings before interest & taxes is -$114.67 million, with the most recent change of -$59.22 million (-106.80%) on December 31, 2024.
  • During the last 3 years, CGON annual EBIT has fallen by -$102.28 million (-825.62%).
  • CGON annual EBIT is now -825.62% below its all-time high of -$12.39 million, reached on December 1, 2021.

Performance

CGON EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

Quarterly EBIT:

-$48.74M-$6.54M(-15.49%)
June 30, 2025

Summary

  • As of today, CGON quarterly earnings before interest & taxes is -$48.74 million, with the most recent change of -$6.54 million (-15.49%) on June 30, 2025.
  • Over the past year, CGON quarterly EBIT has dropped by -$22.89 million (-88.53%).
  • CGON quarterly EBIT is now -423.25% below its all-time high of -$9.31 million, reached on December 1, 2022.

Performance

CGON Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

TTM EBIT:

-$157.29M-$22.89M(-17.03%)
June 30, 2025

Summary

  • As of today, CGON TTM earnings before interest & taxes is -$157.29 million, with the most recent change of -$22.89 million (-17.03%) on June 30, 2025.
  • Over the past year, CGON TTM EBIT has dropped by -$89.61 million (-132.41%).
  • CGON TTM EBIT is now -1588.56% below its all-time high of -$9.31 million, reached on December 1, 2022.

Performance

CGON TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CGON EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-106.8%-88.5%-132.4%
3Y3 Years-825.6%-423.3%-1588.6%
5Y5 Years-825.6%-423.3%-1588.6%

CGON EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-825.6%at low-423.3%at low-1588.6%at low
5Y5-Year-825.6%at low-423.3%at low-1588.6%at low
All-TimeAll-Time-825.6%at low-423.3%at low-1588.6%at low

CGON EBIT History

DateAnnualQuarterlyTTM
Jun 2025
-
-$48.74M(-15.5%)
-$157.29M(-17.0%)
Mar 2025
-
-$42.20M(-10.9%)
-$134.40M(-17.2%)
Dec 2024
-$114.67M
-$38.05M(-34.5%)
-$114.67M(-19.5%)
Sep 2024
-
-$28.30M(-9.4%)
-$95.97M(-41.8%)
Jun 2024
-
-$25.85M(-15.1%)
-$67.68M(-25.0%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$22.47M(-16.1%)
-$54.15M(-70.9%)
Dec 2023
-$55.45M(-57.3%)
-$19.36M(-57.0%)
-$31.68M(-46.4%)
Jun 2023
-
-$12.33M(-32.3%)
-$21.64M(-132.3%)
Dec 2022
-$35.25M(-184.5%)
-
-
Dec 2022
-
-$9.31M
-$9.31M
Dec 2021
-$12.39M
-
-

FAQ

  • What is CG Oncology, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual EBIT year-on-year change?
  • What is CG Oncology, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly EBIT year-on-year change?
  • What is CG Oncology, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for CG Oncology, Inc.?
  • What is CG Oncology, Inc. TTM EBIT year-on-year change?

What is CG Oncology, Inc. annual earnings before interest & taxes?

The current annual EBIT of CGON is -$114.67M

What is the all-time high annual EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual earnings before interest & taxes is -$12.39M

What is CG Oncology, Inc. annual EBIT year-on-year change?

Over the past year, CGON annual earnings before interest & taxes has changed by -$59.22M (-106.80%)

What is CG Oncology, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of CGON is -$48.74M

What is the all-time high quarterly EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly earnings before interest & taxes is -$9.31M

What is CG Oncology, Inc. quarterly EBIT year-on-year change?

Over the past year, CGON quarterly earnings before interest & taxes has changed by -$22.89M (-88.53%)

What is CG Oncology, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of CGON is -$157.29M

What is the all-time high TTM EBIT for CG Oncology, Inc.?

CG Oncology, Inc. all-time high TTM earnings before interest & taxes is -$9.31M

What is CG Oncology, Inc. TTM EBIT year-on-year change?

Over the past year, CGON TTM earnings before interest & taxes has changed by -$89.61M (-132.41%)
On this page